Dr. Uwe Gottschalk, vice president of purification technologies at Sartorius AG (Goettingen, Germany, www.sartorious.com) and member of BioPharm International's editorial advisory board, will now also be a lecturer at the University of Duisburg-Essen, for the first Master's degree program in pharmaceutical medicine.
Dr. Uwe Gottschalk, vice president of purification technologies at Sartorius AG (Goettingen, Germany, www.sartorious.com) and a member of BioPharm International’s editorial advisory board, will now also be a lecturer at the University of Duisburg-Essen, for the first Master’s degree program in pharmaceutical medicine. This internationally focused program is accredited throughout Germany and is designed to qualify medical and scientific students for managerial positions in research, development, approvals, and marketing of pharmaceuticals and medical products. Based in Goettingen, Germany, Dr. Gottschalk will manage the biotechnology study module and lecture on the development and production aspects of biopharmaceutical products.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.